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Abstract RNA interference is a powerful tool for the
functional analysis of proteins by specific gene knockdown.
In this study, we devised a rapid and efficient way to screen
suitable siRNA sequences and subsequently employ them
for specific gene knockdown in usually hard-to-transfect
lymphoid cell lines, using a self-inactivating lentiviral
vector. Two proteins with different half-lives were chosen,
cyclin D1 and STAT3. A specific lacZ reporter fusion assay
was used to identify highly effective siRNA sequences.
Only siRNA molecules with more than 85% of knockdown
efficiency were selected for the generation of lentiviral
transfer vectors. Transduction rates of 75–99% were
achieved in the lymphoma cell lines Granta 519 (mantle
cell lymphoma), Karpas 299, and SUDHL-1 (anaplastic
large T cell lymphoma), as demonstrated by green
fluorescent protein expression in fluorescence-activated cell
sorting analysis. The high level of transduction efficiency
allows RNA interference studies to be performed on
transduced cells without further manipulation, such as cell
sorting or cloning. The LacZ reporter system together with
the lentivirus technology is a very important tool in the
hematology field, which enables experiments in lymphoid
cells that were not possible before.
Keywords RNAinterference.EfficientsiRNA.
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Introduction
Normal lymphocytes and primary tumors, as well as cell
lines of the lymphoid lineage are known to be difficult to
transfect efficiently. Previous attempts to transduce B and T
lymphocytes using retroviruses [1], diethylaminoethyl
dextran, or liposomes [2] have had limited success,
resulting in transfection efficiencies of only 10% to 30%.
This relatively low transfection efficiency is a major
obstacle for siRNA strategies to efficiently test their
contribution to normal biological responses in lymphocyte
populations without further manipulation and cell sorting.
Lentiviruses are an exciting gene delivery tool because of
their ability to efficiently transduce both dividing and
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e-mail: leticia.quintanilla-fend@med.uni-tuebingen.denondividing target cell populations. Additionally, their
capacity to establish long-lasting transgene expression due
to chromosomal integration of the proviral DNA makes this
technique very attractive in the lymphoma research field
[3].
Intense interest in the field of RNAi (RNA interference)
has facilitated its rapid transformation from a biological
phenomenon to a valuable research tool used to silence
target gene expression [4, 5]. RNAi can be mediated either
by small interfering RNAs (siRNAs) of about 21 nucleo-
tides or by stably expressed short hairpin RNAs (shRNAs),
which are processed by Dicer into siRNAs [6, 7]. Two
major problems are evident for studying the lymphocytes
biology: first to achieve their high transfection rate and
second to select the appropriate highly efficient siRNA
sequence. The real challenge of RNAi technology is
designing an effective siRNA sequence [8]. Any region of
mRNA can be targeted; however, sequences that are known
sites for mRNA-binding proteins in the 5′ untranslated
region (UTR), 3′ UTR, start codon, or exon–exon bound-
aries should be avoided [9]. Many groups have demon-
strated that the specific RNAi molecules targeting different
regions of a transcript can vary widely in their effectiveness
at inducing gene silencing [10, 11]. Some recently
published reports advised that chemically synthesized
siRNAs should be employed at low concentrations in order
to prevent unspecific effects, thus underlining the necessity
to select highly efficient siRNAs [12]. Not all rationally
designed si/shRNAs will achieve knockdown of gene
expression at the same level, and, therefore, it is very
desirable to evaluate the silencing capability of several
candidates before committing to the actual experiment.
Many of the proposed guidelines for specific siRNA
design have been incorporated into a variety of public and
commercial computational design tools following the
recommendations originally described by Tuschl and cow-
orkers [13, 14]. Although freely available conventional
siRNA design programs speed the design process, research-
ers are still faced with the task of testing multiple siRNAs
to identify a suitable potent siRNA molecule. Although
siRNA-induced gene silencing is primarily an mRNA-level
event, it is recommended that both mRNA and protein
levels are analyzed. The advantage of analyzing the protein
expression by Western blot is the possibility to quantitate
the knockdown level of the endogenous protein of interest.
The aim of this study is to develop a protocol to achieve
efficient transduction of highly efficient siRNA into B and
T lymphoma cells using a lentiviral vector. For this
purpose, we have chosen STAT3 and cyclin D1 proteins
as targets because the expression of these proteins is
associated with lymphomagenesis and cancer progression
[15, 16], and they have different protein half-lives in the
cells [16–18].
Materials and methods
Design of shRNA constructs and cloning into pSuper
vector
Specific shRNAs were designed by using bioinformatics
tools publicly available from Dharmacon, Invitrogen,
Qiagen, or MWG websites. We designed seven different
sequences for efficient cyclin D1 targeting by shRNA. Of
the four Stat3 shRNAs analyzed, one has been published
[19], and we designed three additional sequences for further
detailed analysis. As a control, “control” siRNA (Dharma-
con Research, Chicago, IL, USA), with the sense sequence
5′-GCCGCUUUGUAGGAUAGAG-3′ which lacks com-
plementary sequences in the human genome, was used.
Oligonucleotides (listed in Table 1) were cloned into
pSuper vector as described [6]. In brief, the double-stranded
DNA templates encoding siRNA oligonucleotides for
cyclin D1 or STAT3 were synthesized. The specific
oligonucleotide sequence contained a sense strand of 19
nucleotides followed by a short spacer (TTCAAGAGA)
and the reverse complement of the sense strand. Five
thymidines were added at the end of synthesized oligonu-
cleotide as RNA polymerase III transcriptional stop signal.
Each pair of oligos was annealed at 20 μM in annealing
buffer (100 mM potassium acetate, 30 mM HEPES–KOH
(pH 7.4), 2 mM magnesium acetate) at 95°C for 4 min,
followed by incubation at 70°C for 10 min and slow
cooling to room temperature. Forty picomolars of annealed
oligos were phosphorylated by T4 polynucleotide kinase
before they were ligated into pSuper vector digested by
BglII and HindIII. All constructs were checked by EcoRI–
HindIII digestion and by sequencing.
Generating the lacZ-cyclin D1 (pLC1) and lacZ-STAT3
(pLS3) screening construct
Ultimate hORF entry clone containing the human cyclin D1
gene (Invitrogen, ORF no. IOH 1962) and human STAT3
gene (Invitrogen, ORF no. IOH 14348), respectively, were
transferred into pSCREEN-iT/lacZ-DEST vector using the
LR recombination reaction with specific enzyme LR
Clonase, characteristic of gateway cloning (Invitrogen,
Carlsbad, CA, USA). Cloning used in this study allows in
vitro recombination-based transfer of DNA from one vector
to another without the use of restriction enzymes. Briefly,
150 ng of destination vector (LacZ-DEST) and 50–150 ng
of entry clone (IOH 1962 or IOH 14348) were mixed in TE
buffer (pH 8.0). LR Clonase enzyme mix (4 μl) was added
and incubated for 1 h at room temperature. Reaction was
stopped with 2 μg of proteinase K solution for 10 min at
37°C. Part of LR reaction (3 μl) was transformed into TOP10
Escherichia-coli-competent cells (Invitrogen, Carlsbad, CA,
10 J Hematopathol (2009) 2:9–19USA) and positive clones were selected on LB plates
containing 100 μg/ml ampicillin (Sigma, St. Louis, MO,
USA). This way, we generated the lacZ-STAT3 (pLS3) and
the lacZ-cyclin D1 (pLC1) in frame fusion screening
constructs.
β-galactosidase assay
Simultaneous delivery of the shRNA constructs with the
pLS3 or pLC1 plasmid induces cleavage of the lacZ fusion
transcript, resulting in reduction of β-galactosidase activity.
The activity of β-galactosidase is directly dependent on the
mRNA stability of the fusion protein. The β-galactosidase
assay was performed using the FluoReporter LacZ/Galac-
tosidase Quantitation kit according to the manufacturer’s
instructions (Invitrogen, Carlsbad, CA, USA). This kit
contains a fluorogenic 3-carboxy-umbelliferyl β-D-galacto-
pyranoside (CUG) substrate from Molecular Probes (cat.
no. F-2905) that allows highly sensitive measurement of
β-galactosidase activity. Briefly, 20 μl of cell lysates or
10
−1 or 10
−2 dilutions were used for measurements in
black-walled clear-bottom 96-well microtiter plates (Costar,
Corning, NY, USA) containing 100 μl of the 1.1-mM CUG
substrate working solution. The reactions were incubated
for 10–30 min at room temperature and stopped by adding
50 μl of stop solution (0.2 M Na2CO3). Fluorescence
emission of the CUG substrate was measured using a
fluorescence plate reader (Fluoroskan Ascent CF reader,
Thermo Scientific, Waltham, MA, USA) equipped with the
proper filter set (excitation filter centered at ∼390 nm and
emission filter centered at ∼460 nm).
Cell culture and transfections
The lymphoma cell lines Granta 519 (mantle cell lymphoma),
Karpas 299, and SUDHL-1 (anaplastic large cell lymphoma)
were cultured in RPMI 1640 supplemented with 10% fetal
bovine serum (FCS), 2 mM glutamine, 100 μg/ml penicillin,
and 100 μg/ml streptomycin (Life Technologies, Inc.,
Gaithersburg, MD, USA). The human embryonic kidney
2 9 3Tc e l l sw e r eg r o w ni nD u l b e c c o ’s modified eagles medium
with 10% FCS, 100 μg/ml penicillin, and 100 μg/ml
streptomycin (Invitrogen, Carlsbad, CA, USA). Transfec-
tions were performed with Lipofectamine 2000 (Invitrogen,
Carlsbad, CA, USA) according to the manufacturer’s
instructions. Typically, cells growing on 60-mm Petri dishes
weretransfectedwith0.5μgre po rt erpl as mi d(p L C1orpL S3 )
and 5.0 μg pSuper empty vector or pSuper with a specific
siRNA sequence (shRNA vector). Cells were analyzed 48 or
72 h after transfection. To estimate the transfection efficiency,
Table 1 Sequences of primers used in this study for shRNA constructs
Primer Sequence
5′3′—sequence of forward primers
shM2_Fw GATCCCCATGTGTGCAGAAGGAGGTCTTCAAGAGAGACCTCCTTCTGCACACATTTTTTGGAAA
shDh1_Fw GATCCCCACAAACAGATCATCCGCAATTCAAGAGATTGCGGATGATCTGTTTGTTTTTTGGAAA
shDh2_Fw GATCCCCCAAACAGATCATCCGCAAATTCAAGAGATTTGCGGATGATCTGTTTGTTTTTGGAAA
shDh3_Fw GATCCCCAACAGATCATCCGCAAACATTCAAGAGATGTTTGCGGATGATCTGTTTTTTTGGAAA
shSA1_Fw GATCCCCGCATGTTCGTGGCCTCTAATTCAAGAGATTAGAGGCCACGAACATGCTTTTTGGAAA
shAS1_Fw GATCCCCTTAGAGGCCACGAACATGCTTCAAGAGAGCATGTTCGTGGCCTCTAATTTTTGGAAA
shGA1_Fw GATCCCCGCATGTTCGTGGCCTCTAAGATTCAAGAGATCTTAGAGGCCACGAACATGCTTTTTGGAAA
shGh1_Fw GATCCCCGCAGCAGCTGAACAACATGTTTCAAGAGAACATGTTGTTCAGCTGCTGCTTTTTGGAAA
shINV1_Fw GATCCCCGCTGAACAACATGTCATTTTTCAAGAGAAAATGACATGTTGTTCAGCTTTTTGGAAA
shDh353_Fw GATCCCCAGTCGAATGTTCTCTATCATTCAAGAGATGATAGAGAACATTCGACTTTTTTGGAAA
shDh1700_Fw GATCCCCTGACTACACTGGCAGAGAATTCAAGAGATTCTCTGCCAGTGTAGTCATTTTTGGAAA
5′3′—sequence of reverse primers
shM2_Rev AGCTTTTCCAAAAAATGTGTGCAGAAGGAGGTCTCTCTTGAAGACCTCCTTCTGCACACATGGG
shDh1_Rev AGCTTTTCCAAAAAACAAACAGATCATCCGCAATCTCTTGAATTGCGGATGATCTGTTTGTGGG
shDh2_Rev AGCTTTTCCAAAAACAAACAGATCATCCGCAAATCTCTTGAATTTGCGGATGATCTGTTTGGGG
shDh3_Rev AGCTTTTCCAAAAAAACAGATCATCCGCAAACATCTCTTGAATGTTTGCGGATGATCTGTTGGG
shSA1_Rev AGCTTTTCCAAAAAGCATGTTCGTGGCCTCTAATCTCTTGAATTAGAGGCCACGAACATGCGGG
shAS1_Rev AGCTTTTCCAAAAATTAGAGGCCACGAACATGCTCTCTTGAAGCATGTTCGTGGCCTCTAAGGG
shGA1_Rev AGCTTTTCCAAAAAGCATGTTCGTGGCCTCTAAGATCTCTTGAATCTTAGAGGCCACGAACATGCGGG
shGh1_Rev AGCTTTTCCAAAAAGCAGCAGCTGAACAACATGTTCTCTTGAAACATGTTGTTCAGCTGCTGCGGG
shINV1_Rev AGCTTTTCCAAAAAGCTGAACAACATGTCATTTTCTCTTGAAAAATGACATGTTGTTCAGCGGG
shDh353_Rev AGCTTTTCCAAAAAAGTCGAATGTTCTCTATCATCTCTTGAATGATAGAGAACATTCGACTGGG
shDh1700_Rev AGCTTTTCCAAAAATGACTACACTGGCAGAGAATCTCTTGAATTCTCTGCCAGTGTAGTCAGGG
The 19- and 21-bp-long specific sense and antisense sequence is presented in bold
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Clontech, Mountain View, CA, USA) was transfected in 293
T cells and the number of GFP-expressing cells was counted
by fluorescence microscopy (Apotome, Zeiss MicroImaging
GmbH, Göttingen, Germany). Transfection efficiencies for
most experiments ranged from 70% to 99%.
Virus production and concentration
The pFUGW transfer vector, the corresponding packaging
plasmid, and the G-protein of vesicular stomatitis virus
envelope plasmid were a kind gift of Dr. Baltimore [3]. The
pFUGW lentiviral vector allows the expression of EGFP
reporter gene driven by an internal ubiquitin-C promoter.
To insert a specific shRNA into the lentiviral vector,
shRNA together with human H1 promoter from pSuper
constructs was digested with SmaI and HincII and ligated
into pFUGW digested with PacI, followed by blunting
using T4 DNA polymerase. The orientations of the frag-
ments were confirmed by ClaI and EcoRI digestion. As
controls, pFUGW derivative vectors containing only an H1
promoter from pSuper plasmid or the control shRNA
sequence under H1 promoter were generated and named
“empty virus” and “control shRNA,” respectively.
Replication-defective lentiviral virions were produced by
transient cotransfection of 7.5 μg pCMVdeltaR8.9, 5 μg
pHCMV-G, and 10 μg of the pFUGW vector or its
derivatives into 293 T cells with the Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) transfection system. The
media was changed 6 h after transfection and supernatant
containing the virus was harvested 48 h after transfection,
cleared of debris by low-speed centrifugation, and filtered
through 0.45-μm Stericup filters (Millipore, Billerica, MA,
USA). Yields were typically 80 to 120 ml from a ten to 15
10-cm dishes. The lentivirus was concentrated by ultrafil-
tration using Amicon-20 100-kDa-molecular-weight cut-off
columns (Millipore, Billerica, MA, USA) in accordance to
the manufacturer’s guidelines. The virus was subsequently
aliquoted (100 μl) and supernatants were stored at −80°C.
Virus titers (multiplicity of infection—MOI) were deter-
mined by fluorescence-activated cell sorting (FACS) anal-
ysis of a known number of 293 Tcells infected with serially
diluted viral supernatant and GFP expression analysis.
Viral infections of suspension lymphoma cell lines
Granta 519, Karpas 299, and SUDHL-1 cells (2×10
6 per
milliliter) were resuspended in lentivirus-containing super-
natant in the presence of polybrene (8 μg/ml) in a six-well
plate. Plates were centrifuged at 1,000 g for 90 min. After
centrifugation, cells were washed, resuspended in fresh
culture medium, and incubated at 37°C in a CO2 incubator
for indicated time points.
Cytofluorimetric analysis (FACS) of infected cells
Three days after infection, cells were washed in phosphate-
buffered saline (PBS) and resuspended in FACS buffer
(PBS with 5% FCS and 1 μg/ml of propidium iodide—PI).
PI was used to determine cell viability of infected cells and
uninfected control. Gene transduction efficiency was
determined by cytofluorimetric analysis using the BD
FACSCalibur™ flow cytometer (BD Biosciences, San Jose,
CA, USA) and analyzed with BD CellQuest Pro™
software. Infected cells were detected on the basis of GFP
fluorescence relative to uninfected control.
Western blot analysis
Cells were washed in PBS, pelleted, and lysed, as described
[20]. The immunoreagents used for Western blot were rabbit
polyclonal antibody against cyclin D1 (H-295; Santa Cruz
Biotechnology, Sc-753) and mouse monoclonal anti-STAT3
antibody (Transduction Laboratories, cat. no. 610190). Mouse
monoclonal antitubulin antibody (Sigma, Clone B512, cat. no.
T-5168) was used as loading control. All experiments were
repeated several times and gave similar results.
Real-time quantitative RT-PCR
Real-time quantitative reverse-transcription polymerase chain
reaction (RT-PCR) analysis was performed with the ABI
Prism 7500 Sequence Detection System (Applied Biosys-
tems, Foster City, CA, USA). For the quantification of cyclin
D1 and STAT3, we used gene expression assays from
Applied Biosystems (cyclin D1, Hs00277039_m1; STAT3,
Hs01047572_m1). TATA box-binding protein (TBP) was
used as the housekeeping gene, as previously described [16].
Target gene expression was normalized to TBP and the target
gene expression was analyzed by the 2ΔΔCT formula. All
reactions were performed at least twice in duplicate.
Results
Determination of knockdown efficiency for STAT3 shRNA
expression vectors
Specific fusion protein lacZ-STAT3 (pLS3) was first
constructed (described in “Materials and methods”)t o
precisely quantify the shRNA effect on STAT3 expression.
The β-galactosidase activity was normalized to 100% with
the activity of the fusion protein in cell extracts from 293 T
cells transfected only with lacZ-STAT3 fusion (pLS3;
Fig. 1a). The knockdown efficiency of four STAT3 shRNA
constructs was investigated. All four designed sequences
for STAT3 knockdown were effective on expression of
12 J Hematopathol (2009) 2:9–19lacZ-STAT3 fusion (Fig. 1a), showing striking reduction in
β-galactosidase activity. The best knockdown effect was
achieved with the constructs pS-Gh1 (97%) and pS-Dh353
(98%), whereas the other two constructs pS-INV1 and pS-
Dh17 showed moderate activity with 80% and 75%
knockdown efficiency, respectively. In order to see whether
the effect was specific, cotransfection of cyclin D1 shRNA–
pSuper expression vector (pS-Dh2) with pLS3 was per-
formed. pS-Dh2 showed induction of lacZ-STAT3 fusion
activity up to 195%, possibly due to the presence of a
negative feedback loop between cyclin D1 and STAT3.
The knockdown effect with the specific STAT3 shRNAs
was corroborated by Western blot analysis of cell extracts
analyzed 48 h after cotransfection of shRNA expression
plasmids with the fusion plasmid (pLS3). The fusion
protein showed a specific protein band of 210 kDa
(Fig. 1b). However, the endogenously expressed STAT3
protein (92 kDa) was not downregulated. Since the half-life
of STAT3 is approximately 72 h, we repeated the
experiment and analyzed the cell extracts of the 293-T-cell
line 72 h after cotransfection with the suitable shRNA
constructs. This time, a complete knockdown with shRNA-
Fig. 1 shRNAs against STAT3
specifically silence lacZ-STAT3
reporter expression as well as
endogenously expressed STAT3
in a 293-T-cell cotransfection
model. a Simultaneous delivery
of different STAT3 shRNAs
with the lacZ-STAT3 fusion
plasmid induces reduction of
β-galactosidase activity.
β-galactosidase activity is nor-
malized to 100% in 293 T cells
transfected only with specific
LacZ fusion. pSuper represents
empty vector control. Cells were
analyzed 48 h after transfection.
b Western blot for STAT3 pro-
tein of cells transfected with
lacZ-STAT3 reporter (pLS3) and
simultaneously with control
plasmid (pSuper) or different
shRNA plasmids (pS-Gh1,
pS-Inv1, pS-Dh353, and
pS-Dh17) 48 h and c 72 h after
transfection. In contrast to the
fusion protein, endogenous
STAT3 disappears only at 72 h
after transfection. The mem-
branes were reprobed with anti-
tubulin to confirm equal loading
J Hematopathol (2009) 2:9–19 13Gh1 was demonstrated for both the fusion (210 kDa)
protein and the endogenously expressed STAT3 protein
(92 kDa) by Western blot (Fig. 1c).
Determination of knockdown efficiency for cyclin D1
shRNA expression vectors
Seven H1 RNA promoter-mediated shRNA expression
vectors to target cyclin D1 mRNA were constructed. The
bioinformaticstoolsusedfordesignwerefromMWG(pS-M2
construct), Dharmacon (pS-Dh1, pS-Dh2, and pS-Dh3), and
Invitrogen (pS-SA1, pS-AS1, and pS-GA1 constructs). All
constructs have a 19-bp-long specific sense sequence, except
pS-GA1, which has 21 bp (it has the same 19 bp like pS-SA1
plus two extra base pairs up to 21; see Table 1). Constructs
pS-Dh1, pS-Dh2, and pS-Dh3 were designed in the same
coding region of cyclin D1 and have 1- or 2-bp differences
(see alignment below).
pS-Dh1 ACAAACAGATCATCCGCAA
           ||||||||||||||||||
pS-Dh2 CAAACAGATCATCCGCAAA
             |||||||||||||||||
pS-Dh3    AACAGATCATCCGCAAACA
With these seven oligos for cyclin D1, we tried to cover the
main regions for efficient siRNA silencing proposed by
different bioinformatics web tools.
To precisely quantify the shRNA effect on cyclin D1,
specific fusion protein lacZ-cyclin D1 (pLC1, described in
“Materials and methods”) was constructed and transfected
into the 293-T-cell line. Cotransfection of pSuper (pS)
empty vector or control (pSS) shRNA sequence with pLC1
did not change the expression of the fusion protein
significantly. Constructs pS-Dh1, pS-Dh3, and pS-SA1
were characterized as moderately active molecules with a
knockdown efficiency of 80%. Construct pS-Dh2 was
characterized as highly active shRNA with 96% of
knockdown efficiency. The other shRNAs failed to show
significant activity. Construct pS-Gh1, with the best
knockdown efficiency for STAT3, was used as an indepen-
dent control for specificity of the lacZ-cyclin D1 fusion
knockdown. Cotransfection of STAT3 shRNA-Gh1 with
fusion plasmid (pLC1) showed no effect on lacZ-cyclin D1
expression in the 293-T-cell line (Fig. 2a).
The relationship between the knockdown effect on
cyclin D1 protein and β-galactosidase assay was analyzed
by Western blot from 293-T-cell extracts prepared 48 h after
transfection either with lacZ-cyclin D1 fusion (pLC1) alone
or cotransfected with specific shRNA constructs (Fig. 2b).
The strongest reduction in β-galactosidase activity was
induced by pS-Dh2, followed by pS-SA1 construct
(Fig. 2a), which showed an excellent correlation with the
Western blot results. Both the fusion protein (156 kDa) and
the endogenous cyclin D1 (36 kDa) were completely
downregulated by pS-Dh2, whereas pS-SA1 showed strong
but not complete downregulation of the fusion protein.
Sensitivity and reproducibility of the β-galactosidase assay
To determine the sensitivity of the method in more detail,
we used different ratios of reporter plasmid pLC1 in
cotransfection with the shRNA vectors. Figure 3 shows
the effect of shRNA constructs when 100, 500 ng, or 1 μg
of reporter plasmid (pLC1) were used. The best ratio to
compare and to find the best shRNA with the highest
efficiency is 500 ng of reporter with 5 μg of shRNA vector
(ratio 1:10). Vector pS-Dh2 was highly active with all
analyzed concentrations of reporter, indicating that it is the
most efficient construct. The efficient downregulation of
the target protein with the same shRNA was achieved
independent of protein expression level in the cell, as
evidenced by comparison of knockdown in 293 T cells with
endogenous expression of cyclin D1 and lacZ-cyclin D1
fusion expression (Fig. 2b).
Efficient transfer of cyclin D1 shRNA in B cell lymphoma
cells using lentiviral vector
Since lentiviruses can infect a wide range of dividing and
nondividing cells, we tested whether the lentiviral vector
pFUGW can be used for siRNA-mediated gene silencing in
human lymphoma cell lines. The most efficient construct in
β-galactosidase assay for cyclin D1 (Fig. 3), pS-Dh2, was
used for lentivirus transfer vector production. The resulting
lentiviral vector pF-Dh2 was packaged and first titrated on
293 T cells for determination of MOI. To identify the titer
required for efficient transduction, the mantle cell lymphoma
cell line Granta 519 was transduced with increasing MOI
(15, 45, and 90; Fig. 4a–c). Although the viability (65%) and
the transduction efficiency was equally good with the
different MOI, the amount of shRNA in the cells was
increasingly higher with 45 and 90 MOI, as judged by the
intensity of GFP in the FACS analysis (Fig. 4a). Western blot
analysis showed an excellent correlation between cyclin D1
protein expression and the amount of MOI used, with
practically complete knockdown of cyclin D1 with 90 MOI
(Fig. 4b). However, quantitative RT-PCR of cyclin D1
mRNA demonstrated similar cyclin D1 levels between 45
and 90 MOI, whereas, with 90 MOI nonspecific down-
regulation of cyclin D1 mRNA was observed in the controls
(Fig. 4c). Therefore, 40–45 MOI were used for all
subsequent experiments in lymphoma cell lines. In Granta
519 cells and corresponding controls, high levels (98% on
average) of GFP were expressed 3 days after transduction,
with specific cyclin D1 downregulation as shown in Fig. 4b.
14 J Hematopathol (2009) 2:9–19Fig. 3 Sensitivity and reproduc-
ibility of β-galactosidase assay.
Different ratios of different
shRNA plasmids and reporter
fusion (pLC1) in cotransfection
were employed. Concentration
of shRNA plasmids for cotrans-
fection was constant (5 μg) and
pLC1 was 100 ng (light gray
boxes), 500 ng (gray boxes), and
1 μg( dark gray boxes). Cells
were analyzed 48 h after
transfection
Fig. 2 shRNAs against cyclin
D1 are able to specifically si-
lence lacZ-cyclin D1 reporter
expression and endogenously
expressed cyclin D1. a Cotrans-
fection of different shRNA con-
structs for cyclin D1 with lacZ-
cyclin D1 reporter fusion
(pLC1). shRNA effect was
measured 48 h after transfection
by β-galactosidase assay.
pSuper and pS control represent
controls with empty vector and
pSuper with control shRNA se-
quence, respectively. STAT3
shRNA-Gh1 was used as an
irrelevant control for lacZ-cyclin
D1 reporter expression. b West-
ern blot for cyclin D1 demon-
strates striking reduction of both
endogenous cyclin D1 as well as
fusion protein in the cells
cotransfected with specific
shRNA constructs (pS-Dh2 and
pS-SA1) 48 h after transfection.
The same membrane was
reprobed with anti-tubulin
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lymphoma cells using lentiviral vectors
The most efficient construct in β-galactosidase assay for
STAT3 (Fig. 1), pS-Gh1, was used for lentivirus transfer
vector production (pF-Gh1). ALK+ anaplastic large T cell
lymphoma cells (Karpas 299 and SUDHL-1) were exposed
to supernatant containing lentiviral particles at 40 MOI in
one round of infection. Karpas 299 control and infected
cells were 93% viable 3 days after infection and on average
80% infected (Fig. 5a). SUDHL-1 control and infected cells
were 43% viable 3 days after infection and 99% infected
Fig. 4 Successful infection of B cell lymphoma cells (Granta 519)
with lentivirus. a The efficiency of viral infection was analyzed,
detecting GFP expression by FACS. Granta 519 control cells and
infected cells were 65% viable 3 days after infection and infection
ranged between 93.2% and 98.9%, dependent of MOI (15, 45, 90)
used for transduction. b Specific knockdown effect for cyclin D1 was
shown by Western blot from cell extracts prepared 3 days after
infection with different MOI, for corresponding controls and cyclin
D1 shRNA-Dh2. c qRT-PCR analysis of cyclin D1 mRNA was
performed relative to the TBP housekeeping gene. Results are
depicted as mRNA concentration relative to the control uninfected
cells (Granta 519-c). Data were analyzed according to the ΔCT
method
16 J Hematopathol (2009) 2:9–19(Fig. 5b). The level of knockdown effect for STAT3 was
analyzed by Western blot from cell extracts prepared 3 days
after infection (Fig. 5c). The specific downregulation of
STAT3 protein correlated with the amount of transfected
cells. Karpas 299, which showed around 80% transduction,
had a strong reduction of STAT3 protein, whereas SUDHL-
1 cells with 99% of viral infection showed complete
inhibition of STAT3 protein. None of the cell lines showed
side effects in the controls. To evaluate the stability of the
lentivirus infection and siRNA-mediated gene silencing, we
analyzed the GFP expression at several time points after
gene transduction of Granta 519 and Karpas 299 cells. The
percentage and the mean fluorescence intensity of GFP-
positive cells were maintained over the time course, and
importantly the GFP-positivity was also maintained even
after freezing and thawing the cells (data not shown).
Discussion
In this study, we have successfully used a combination of two
techniquestoachieveefficienttransductionofspecificshRNA
with high knockdown efficiency into B and T lymphoma
cells,withinfectionratesintherangeof80%to99%.Thefirst
technique is a highly sensitive β-galactosidase reporter assay
b a s e do nas p e c i f i clacZ reporter fusion with the
corresponding gene of interest that enables fast and easy
recognition of the most efficient siRNA sequence for target
knockdown. The second technique requires RNAi molecules
with more than 85% of knockdown efficiency that are further
cloned into a lentiviral vector (pFUGW) [3] for virus
production and successful transduction of lymphoma cell
lines.
The need for a strong specific gene silencing effect by
RNAi means there is an absolute requirement to test the
specificity and efficiency of siRNAs before embarking on
phenotype analysis [8, 21]. Although it is expected that
chemically synthesized siRNAs and corresponding hairpin-
based shRNAs should have the same gene knockdown
effect, it has been shown that si/shRNAs exhibit similar but
not identical sequence preferences [22]. With the approach
described here, the generation of constructs is straightfor-
ward, relying on the use of synthetic oligonucleotides and a
single restriction site that ensures directional cloning. The
sensitivity of the LacZ reporter fusion system allows the
identification of RNAi molecules that are the most potent in
inducing target gene knockdown even at protein level. In
this study, two proteins that have been recognized to be
important in lymphomagenesis were chosen, cyclin D1 with
a short half-life and STAT3 with a long half-life. In both
instances, efficient knockdown activity of the fusion protein
with specific shRNA was achieved. Since no preexisting
pool of the LacZ fusion protein is available in the 293 T
cells, the protein half-life to evaluate the shRNA efficiency
is not an issue. Using this validation approach, it is very
simple to identify the shRNAs that are most effective at
knocking down the target gene. Nevertheless, when specific
shRNA is used for knockdown of endogenous proteins, the
half-life of the protein has to be taken in consideration to
decide the right time of the experiment. This was evidenced
in this study by STAT3 protein, where a big difference in
knockdown efficiency was seen after 48 or 72 h, respec-
tively. In addition, we demonstrated that assessment of
shRNAs is not influenced by the amount of the reporter
construct used for analysis since the most effective shRNA
is reliably identified after cotransfection with both low
(100 ng) and high (1 μg) concentration of the fusion gene.
For successful inhibition of target genes, the efficiency
of the shRNA molecules and infection rate of the target
cells are the two critical parameters. On one side, only
shRNA molecules with more than 85% of knockdown
efficiency (highly efficient) should be considered to further
generate lentiviral transfer vectors and complex lentivirus
production. On the other side, the optimal MOI should be
established for each cell population to be analyzed [23, 24].
Our data describe the conditions of infection required for
optimal gene transduction for lymphoid cell lines, which
may have to be modified for other types of target cells. The
limiting factor for high transduction rate and the main
difference between viral infection of adherent cells and
suspension cells is the centrifugation step, during which
viral infection occurs in the latter. Since there is less contact
between viral particles and suspension cells as compared to
adherent cells, higher infection units per cell are needed to
obtain efficient transduction. The fraction of infected cells
rises with increasing MOI and reaches a plateau between 35
and 45 MOI. This is the optimal point where the highest
levels of gene knockdown are achieved, with a minimum of
nonspecific effects. However, we have encountered lym-
phoma cell lines where much higher MOI (up to 80) are
needed to achieve around 80% of cell transduction (data not
shown). The lentiviral vectors have the advantage to remain
stable within the cell for long periods of time [25]. The
monitoring of GFP expression by FACS analysis not only
gives information about the amount of transduced cells but
also about the stability of the transduction. GFP expression
was analyzed up to 12 weeks, and its expression remained
stable even after cell freezing and thawing.
In summary, we describe the use of the lentiviral vector
system to obtain highly efficient and long-term repression
of gene expression in lymphoid cell lines, which represents
a major improvement over previously published methods
[1, 2, 25]. The high ability of lentivirus to transduce
lymphoma cells and to achieve high knockdown effect
through RNAi opens new avenues for genetic characteriza-
tion and provides a useful tool for basic molecular studies
J Hematopathol (2009) 2:9–19 17Fig. 5 Successful infection of T cell lymphoma cells (Karpas 299 and
SUDHL-1) with lentivirus. The efficiency of viral infection was analyzed,
detecting GFP expression by FACS. a Karpas 299 noninfected and
infected cells were 90% viable 3 days after infection and on average 75%
infected. b SUDHL-1 control and infected cells were 43% viable 3 days
after infection and 99% infected. c The level of knockdown effect for
STAT3 was analyzed by Western blot from cell extracts prepared 3 days
after infection with corresponding controls and STAT3 shRNA-Gh1. The
specific downregulation of STAT3 protein was shown in the infected cells
and no side effects were seen when membrane was probed with anti-
ALK1. The same membrane was probed with anti-tubulin. d qRT-PCR
analysis of STAT3 mRNA was performed relative to the TBP
housekeeping gene. Results are depicted as mRNA concentration relative
to Karpas 299 (light gray boxes) and SUDHL-1 (gray boxes) control cells.
Data were analyzed according to the ΔCT method
18 J Hematopathol (2009) 2:9–19of lymphoma cell biology and therapy regimens. The high
level of transduction efficiency (85% on average) will allow
RNA interference studies to be performed on transduced
populations of cells without further manipulation such as
cell sorting or cloning.
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